The Pharmacokinetics and Pharmacodynamics of Micafungin in Experimental HematogenousCandidaMeningoencephalitis: Implications for Echinocandin Therapy in Neonates

This publication has 29 references indexed in Scilit:

• Optimization of the Dosage of Flucytosine in Combination with Amphotericin B for Disseminated Candidiasis: a Pharmacodynamic Rationale for Reduced Dosing
  Antimicrobial Agents and Chemotherapy, 2007
• SUCCESSFUL MEDICAL TREATMENT OF CUTANEOUS ASPERGILLOSIS IN A PREMATURE INFANT USING LIPOSOMAL AMPHOTERICIN B, VORICONAZOLE AND MICAFUNGIN
  The Pediatric Infectious Disease Journal, 2007
• Drug delivery across the blood–brain barrier: why is it difficult? how to measure and improve it?
  Expert Opinion on Drug Delivery, 2006
• Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months
  Pediatrics, 2006
• Pharmacodynamics of Caspofungin in a Murine Model of Systemic Candidiasis: Importance of Persistence of Caspofungin in Tissues to Understanding Drug Activity
  Antimicrobial Agents and Chemotherapy, 2005
• Echinocandin antifungal drugs
  The Lancet, 2003
• Candidal Meningitis in Neonates: A 10-Year Review
  Clinical Infectious Diseases, 2000
• Comparative Efficacy and Distribution of Lipid Formulations of Amphotericin B in ExperimentalCandida albicansInfection of the Central Nervous System
  The Journal of Infectious Diseases, 2000
• Altered Tissue Distribution of Amphotericin B by Liposomal Encapsulation: Comparison of Normal Mice to Mice Infected with Candida albicans
  Cancer Drug Delivery, 1984
• Pharmacology and Efficacy of Vancomycin for Staphylococcal Infections in Children
  Clinical Infectious Diseases, 1981